S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › ALHYP › Research report
← ALHYP page
XStocksXray
Market X-Ray report · 19 October 2026

Hipay Group SA (ALHYP)

Euronext Paris · France · prices in EUR · close of 19 Oct 2026

Key indicators

Last closeEUR 4.240
52-week range3.830 – 9.880
Return, 1 month / 3 months−8.2% / −21.8%
Return, 1 year / 3 years−55.1% / −34.3%
TrendBelow its 200-day average
RSI (14)44
Volatility (1 year)54.5%
Worst drawdown (1 year)-60.4%
Average daily value traded0.02M EUR
Dividend yield–

Market X-Ray price-based

24/ 100 · High confidence · ahead of 13% of stocks on this exchange
Trend19
Momentum16
Stability (higher is calmer)26
Liquidity42
Income–

Five-year price chart navy: price · brown: 200-day average

1.867.5213.1818.8424.512021-112023-012024-042025-072026-10

About the company

Hipay Group is a French payments company that provides online payment processing and related merchant services. It helps businesses accept payments over the internet and offers tools for managing transactions, fraud checks and payment flows. Its customers are mainly merchants and digital businesses that need to take payments online, and the company is based in France, where it serves clients across Europe.

The shares are listed on the Euronext Paris in France under the code ALHYP, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Hipay Group SA (ALHYP) trades on the Euronext Paris in France. It last closed at EUR 4.240 on 19 October 2026.

Its price-based Market X-Ray is 24 out of 100 (a weak price profile), ranking 544 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 55.1% and over the last three months it fell 21.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Hipay Group SA (ALHYP)

The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris

Lens and metricValueScoreReading
Trend19 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-22.9%
From 52-week high-56.9%
Momentum16 · WeakLagging most stocks on this exchange.
3-month return-21.8%
6-month return-32.5%
12-month return, skipping the last month-51.1%
Stability (higher is calmer)26 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)54.5%
Worst drawdown, 1 year (smaller is calmer)-60.4%
Liquidity42 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.02M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−2.3%
1 month−8.2%
3 months−21.8%
6 months−32.5%
1 year−55.1%
3 years−34.3%
5 years−74.9%

Signals

50-day / 200-day average4.716 / 5.500
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.199

Technical summary

DailyBearish3 bullish · 4 neutral · 9 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 11 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026